<DOC>
	<DOC>NCT00223509</DOC>
	<brief_summary>- To evaluate the efficacy and safety of LAM+existing regimen of mood stabilizer in the acute treatment of patients in a mixed state of bipolar disorder. - To evaluate the efficacy and of a combination of LAM+existing regimen of mood stabilizers in the maintenance treatment of patients with mixed state of bipolar disorder</brief_summary>
	<brief_title>Lamictal As Add on Treatment in Mixed States of Bipolar Disorder</brief_title>
	<detailed_description>1. To evaluate the efficacy and safety of LAM+existing regimen of mood stabilizer in the acute treatment of patients in a mixed state of bipolar disorder. 2. To evaluate the efficacy and of a combination of LAM+existing regimen of mood stabilizers in the maintenance treatment of patients with mixed state of bipolar disorder</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>In order to be included in the study patient must meet criteria A, C, D, E, F, G plus any 1 of the 3 criteria listed in section B. A. Patients meeting DSMIV diagnosis of bipolar disorder, I or II B. 1. Patients meeting DSMIV diagnostic criteria for a manic/hypomanic episode with the simultaneous presence of (or rapid alteration within minutes) of at least three DSMIV depressive symptoms excluding psychomotor agitation or 2. Patients meeting DSMIV symptomatic criteria for a hypomanic/manic episode for a period of 2 days or longer, with the simultaneous presence of (or rapid alteration within minutes) of at least three DSMIV depressive symptoms excluding psychomotor agitation or 3. Patients meeting DSMIV criteria for a depressive episode associated with at least three DSMIV manic/hypomanic symptoms C.MADRS of ≥14 D.YMRS of ≥ 14 E. Age 13years to 75 years F. Male or female G. Outpatient 1. illness precluding the use of LAM 2. Alcohol/drug dependence in the past one month 3. patients with a history of a rash on LAM 4. CNS neoplasms, demyelinating diseases, degenerative neurological condition or active CNS infection 5. history of seizure, known EEG with frank paroxysmal activity, known CT of brain showing gross structural abnormalities, cerebral vascular disease by history or structural brain damage from trauma 6. patients currently taking LAM</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>mixed mania</keyword>
	<keyword>lamotrigine</keyword>
</DOC>